中國醫療集團:截至二零二三年十二月三十一日止之年度報告
C HEALTH GP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
China Healthcare Group (08225): Liu Na appointed as independent non-executive director
China Medical Group (08225) announced that Liu Na has been appointed as an independent non-executive director of the company, starting in 2024...
China Medical Group (08225) appoints Wang Dajun as non-executive director
China Medical Group (08225) issued an announcement. Due to work reasons, Qiu Rui has proposed his resignation and resigning his independence from the company...
China Medical Group (08225.HK): CHG China Medical Group affiliates reached clinical research and promotion cooperation agreements with Yueyang Xinhuada Pharmaceutical and Shandong Langnuo Pharmaceutical on children's psychosocial treatment drugs
China Medical Group (08225.HK) announced that CHG China Medical Group affiliates have reached clinical research and promotion cooperation agreements with Yueyang Xinhuada Pharmaceutical Co., Ltd. and Shandong Langnuo Pharmaceutical Co., Ltd. on children's psychosocial treatment drugs. The above cooperation will play a strong role in promoting the company's business development.
C HEALTH GP: THIRD QUARTERLY REPORT 2023
China Medical Group (08225) announced the first three quarter results, net profit of 5.934 million yuan, up 29.9 times year-on-year
China Medical Group (08225) announced the results for the first three quarters of 2023, with an operating income of approximately RMB 1789.4...
C HEALTH GP: RESULTS ANNOUNCEMENT FOR THIRD QUARTERLY OF 2023
C HEALTH GP: CLARIFICATION ANNOUNCEMENT
China Medical Group (08225.HK): All offline academic activities have returned to normal since 2023
GLONGHUI, September 11丨China Medical Group (08225.HK) announced that due to the irresistible factors of the COVID-19 pandemic, all of the company's academic activities began in early 2022 from offline to online. There is still a certain gap between the effectiveness of online academic research activities and the results of offline research activities. There is also an obstacle to patient case collection. Later, customers raised objections one by one and did not acknowledge the service results. Since the online campaign is in the initial implementation stage and long-term cooperation with customers is being considered, after discussions with management and instructions from the board of directors, the financial staff also reviewed the parts previously determined during the pre-annual review period after the company released the third quarter results
C HEALTH GP: Clarification Announcement Interim Report and Interim Results for the six months ended June 30, 2023
C HEALTH GP: INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2023
C HEALTH GP: ANNOUNCEMENT OF INTERIM RESULTS 2023 FOR THE SIX MONTHS ENDED 30 JUNE 2023
C HEALTH GP: ANNOUNCEMENT OF INTERIM RESULTS 2023 FOR THE SIX MONTHS ENDED 30 JUNE 2023
C HEALTH GP: Notice of the Board meetings
C HEALTH GP: Supplementary Announcement to the Annual Report for the year ended 31 December 2022
C HEALTH GP: Report for the first quarter of 2023
China Healthcare Group (08225.HK)'s revenue of 4 million yuan in the first quarter fell by about 71.73% year-on-year
Gelonghui, May 15 丨 China Healthcare Group (08225.HK) announced that for the three months ending March 31, 2023, the company recorded revenue of about RMB 4 million, a year-on-year decrease of about 71.73%. Profit before tax was recorded at about RMB 1.05 million for the current period, down about 87.62% from profit before tax for the same period in 2022.
C HEALTH GP: Results announcement for the first quarter of 2023
China Healthcare Group (08225) has announced its 2022 results and trading will resume on April 17
According to the Zhitong Finance App, China Healthcare Group (08225) announced that trading of the company's shares will resume at 9:00 a.m. on April 17, 2023.
No Data